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linical Significance of Iodine-123
etaiodobenzylguanidine
ardiac Imaging
n a recent issue of the Journal, Tamaki et al. (1) found that in their
tudy sample of 106 consecutive patients with stable congestive
eart failure (CHF), those experiencing a sudden cardiac death
SCD) had on average a higher washout rate of iodine-123
etaiodobenzylguanidine (MIBG WR) compared with those who
urvived. Statistically, the cardiac MIBG WR was a powerful
redictor of SCD in patients with mild-to-moderate CHF. But
ow can this best be applied clinically?
The mean (X1) washout rate in those with SCD was 39.9%
ith a standard deviation (SD1) of 15.2%. For those without
CD, the mean (X2) washout rate was 27.6% with a standard
eviation (SD2) of 14.2%. Using this data, we can determine the
rossover point below which a patient is more likely than not to fall
nto the low-risk group (no SCD) and above which a patient is
ore likely than not to fall into the high-risk group (SCD) (2).
The crossover point (CP)  (SD1 · X2  SD2 · X1)/(SD1 
D2)  33.5%. This CP falls 0.42 SDs above X2 and 0.42 SDs
elow X1 (i.e., X2 0.42 · SD2 X1 0.42 · SD1). In normally
istributed data, using a z-score table, we find that, at best, 34% of
he patients will be miscategorized when using the MIBG WR iffixed threshold value is utilized. If we use a threshold of 27%, as
roposed by Ogita et al. (3), then over 50% of the low-risk patients
ill be miscategorized. Threshold values either above or below the
P will only lead to a miscategorization rate 34%.
In clinical practice, fixed threshold values for continuous data
uch as the MIBG WR are not rigidly followed. Patients are
requently categorized as “borderline normal” or “borderline ab-
ormal.” Are there better ways to make sense of the data so it can
e more clinically useful? Simply reporting the means, SDs, and a
hreshold value does not adequately characterize the data for the
linician caring for an individual patient.
We propose that a more useful way to report continuous
ariables that impact patient care is to give at least 3 reference
alues: 1) the point where an individual patient is just as likely as
ot to belong to group 1 as to group 2; 2) the odds of belonging
o group 1 at X1; and 3) the odds of belonging to group 2 at X2.
n some situations, additional reference values may be useful. For
he MIBG WR data, the CP  33.5%. This is the point at which
he odds are 50/50 in regard to whether the patient is in the
igh-risk or in the low-risk group. The formula to determine this
oint is given in the preceding text.
When a patient’s MIBG WR is 39.9% or greater, the odds are
t least 2.6 to 1 that the patient is in the high-risk group. This is
alculated by finding the z-score of the absolute value of (X1 
2)/SD2, then dividing 0.5 by the area under the curve to the right
f this z-score. When a patient’s MIBG WR is 27.6% or less, the
dds are at least 2.4 to 1 that the patient is in the low-risk group.
his is calculated by finding the z-score of the absolute value of
X1  X2)/SD1, then dividing 0.5 by the area under the curve to
he right of this z-score.
This type of numerical summary helps clinicians reasonably
pply and explain the MIBGWR to individual patients with stable
HF. When a patient’s MIBG WR is around 33%, the test does
ot help categorize the patient into a low- or high-risk category (a
oin flip is just as accurate). However, when the MIBG WR is
7% or less, the odds are greater than 2:1 that the patient is at low
isk. When the MIBG WR is 40% or higher, the odds are greater
han 2:1 that the patient is at high risk. Basing medical manage-
ent upon MIBG WR values between 30% and 36% is basically
ust guessing, and will lead to suboptimal care in a high percentage
f patients.
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eply
e are grateful to Drs. Heston and Wahl for their valuable
omments and suggestions to our study (1). They pose a question
egarding the use of a fixed threshold value for continuous data,
uch as a washout rate of iodine-123 metaiodobenzylguanidine
MIBG WR) for the prediction of prognosis, and propose an
lternative way to figure out and report such continuous variables.
lthough the method they propose is indeed intriguing, we think
here remain a few important problems to be discussed.
First, the clinical implication of the reference values that they
ropose would vary depending on the outcome to which the contin-
ous variable is related. For example, in the case where the outcome
s sudden cardiac death (SCD) as in our study, the patients with
ariables near the crossover point would be regarded as life-
hreatened patients, because they may belong to those with a high
isk of SCD, at a rate as high as 50%. Such patients might be
egarded as the good candidates for implantable cardioverter-
efibrillator therapy in most cases.
In dealing with the issues of life-threatening events like SCD,
e think we should put more emphasis on not overlooking the
atients at high risk than on not overlooking those at low risk. The
hreshold of MIBG WR 27% would be appropriate for this
urpose, because a negative predictive value as high as 92% could
e achieved with this threshold in our study patients (1).
Second, there may be a limitation on the method by Drs.
eston and Wahl, because their calculation is based on the
ssumption that the results of cardiac MIBG WR exactly follow a
ormal distribution. In fact, the specificity of abnormal MIBG
R (27%) for the prediction of SCD was 56% (1), which isifferent from (higher than) the specificity calculated by Drs.
eston and Wahl.
However, we agree with the suggestion by Drs. Heston and
ahl that there are some borderline cases that require difficult
ecision making, and that we should not rely only on the fixed
IBG WR value for the identification of the patients at high risk
or SCD. The only way to deal with these borderline cases might
e to take other clinical indexes that have been shown to be highly
redictive of SCD (i.e., left ventricular ejection fraction, electro-
ardiographic parameters such as T-wave alternans [2], or clinical
cores [3]) into account and judge the risk for SCD on a case by
ase basis.
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